Microbiome transplantation and modulation of immune related adverse events
Open Access
- 1 February 2019
- journal article
- editorial
- Published by Elsevier BV in EClinicalMedicine
- Vol. 8, 10-11
- https://doi.org/10.1016/j.eclinm.2019.03.003
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitisNature Medicine, 2018
- The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer ImmunotherapyCancer Cell, 2018
- The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patientsScience, 2018
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patientsScience, 2018
- Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumorsScience, 2018
- The Human Microbiome and CancerCancer Prevention Research, 2017
- Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumabAnnals of Oncology, 2017
- Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitisNature Communications, 2016
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiotaScience, 2015
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacyScience, 2015